Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
about
Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic ImplicationsRisk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancersRectal cancer: An evidence-based update for primary care providersRectal cancer stagingPredictive Response Value of Pre- and Postchemoradiotherapy Variables in Rectal Cancer: An Analysis of Histological DataPhase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.Clinical significance of tumor regression grade in rectal cancer with preoperative chemoradiotherapyNeutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancerNeoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.Patterns of local recurrence in rectal cancer after a multidisciplinary approach.A pilot feasibility study of TNFeradeā¢ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancerLymph node retrieval in abdominoperineal surgical specimen is radiation time-dependent.Neoadjuvant treatment in rectal cancer: actual status.MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.Treatment of locally advanced rectal cancer: controversies and questions.Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancerDoes Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer.Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer.Tumor regression grades: can they influence rectal cancer therapy decision tree?Local recurrence after curative resection for rectal carcinoma: The role of surgical resection.Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer.Adjuvant therapy for rectal cancerCurrent issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapyRadiation therapy for rectal cancer: current status and future directions.The clinicopathologic relevance and prognostic value of tumor deposits and the applicability of N1c category in rectal cancer with preoperative radiotherapyA scoring system basing pathological parameters to predict regional lymph node metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer: implication for local excision.Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials.Multidisciplinary management in rectal cancer.Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis.Predicting the response to preoperative radiation or chemoradiation by a microarray analysis of the gene expression profiles in rectal cancer.Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results?Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?Prognostic value of mandard and dworak tumor regression grading in rectal cancer: study of a single tertiary center.Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy?Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.Neoadjuvant treatment of mid-to-lower rectal cancer with oxaliplatin plus 5-fluorouracil and leucovorin in combination with radiotherapy: a Korean single center phase II study.Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine.Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response.
P2860
Q26778222-C880C3B0-F8F6-48F0-8B50-EED27CB85CEDQ26853016-27759E9B-C87F-47DB-8B5E-19B60BE55520Q27013068-251FD4C0-F030-4850-BBF1-E2E95F76ABD4Q30484651-7F53B0E2-5F05-4945-ABA7-62D90A536EC4Q31046735-60F6FB8F-B483-4FB8-8C00-0F6EA1FBF7E5Q33848566-50002CF2-652C-4811-8E85-A9E0043CB484Q34169310-2DAC34E7-2F89-495C-9425-D3D66EE0E0CBQ34385284-26EDC379-087C-462C-8443-5F99F685A5B7Q34566054-5588CC7A-F882-4A87-BE1A-9B1E508EDB1DQ34599442-95CB98FC-E2F6-46B2-A143-9F98C708DE7CQ34771979-965D3846-0004-4CD7-90CC-4B05EAD2825AQ34803980-E23F52CD-1464-456C-95E5-2A73550DC8FEQ34880940-86ED4AC2-98CD-4817-B35D-C956E2531ECDQ35687452-32F1EE62-F85F-4A63-AC0F-CC80A39D35EFQ35885124-47C214D1-93D4-4057-AA63-427324CF9BD1Q36351882-809FD464-2E57-4887-A951-E6E58AC28FDCQ36608511-DAF369C6-63D3-4616-88C5-52FB900C89CBQ36880544-64D77BBA-5219-44ED-BEF1-EBD7B77A562DQ37046615-C79E8DF3-70F4-4DE8-92D0-15A867CD30FFQ37140736-A0C3958F-B6A0-4DF2-848E-7F6B43E5615CQ37239808-840991D0-31E3-499B-8AF4-F7E170CEFB76Q37327881-C1D04529-6D0D-4ED9-AB83-E1344F9581D1Q37343466-0E1900EF-C751-4D8F-BDE2-583FCB68636FQ37462241-D29D5DA3-8DB1-4846-A55D-C7AFA18ED0C6Q37602735-C4900C9C-1B64-429A-BE40-F7378B285083Q37654670-B182BA41-E679-421B-9BCB-04662853A6CCQ37688901-44670296-1248-4F7A-8F61-CF08ECE0DBD4Q37694658-61E11A54-55CF-4E1B-9CB0-E4FD7C682C3AQ37709739-5DCC3D0F-8148-4A90-9D2A-FA2413CA5A82Q37820756-26BE354D-7E0B-4A5F-AC1D-6B1CF1768202Q37995506-06C464CA-0ABE-4FD1-9B92-FD7DB9654860Q38019396-34A104B9-0022-42F4-9FF4-D405EE736F6BQ38236794-CE7A1BBF-7BEB-484E-BB94-41DA87C24BEFQ38285536-7CA3F162-F077-43A9-93F0-E5B82595D5DEQ38367857-F5C16649-6057-4623-96EA-6D0E9B99FE57Q38464448-8F5CB1A4-5AAA-4300-B4E7-A512892128B5Q39796757-C4206AE0-F07B-4CC0-9D6D-16B4BB8423A1Q42637103-142E3C95-56C5-4318-87BB-235CA3A5A184Q42974975-A2FE4D08-0C50-46BD-A899-2FFA4CF2BE55Q43048706-2F51E0C8-B619-4C84-8159-94C850B21419
P2860
Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
description
2005 nĆ® lÅ«n-bĆ»n
@nan
2005幓ć®č«ę
@ja
2005幓å¦ęÆęē«
@wuu
2005幓å¦ęÆęē«
@zh
2005幓å¦ęÆęē«
@zh-cn
2005幓å¦ęÆęē«
@zh-hans
2005幓å¦ęÆęē«
@zh-my
2005幓å¦ęÆęē«
@zh-sg
2005幓åøč”ęē«
@yue
2005幓åøč”ęē«
@zh-hant
name
Posttreatment TNM staging is a ...... chemotherapy and radiotherapy.
@en
Posttreatment TNM staging is a ...... chemotherapy and radiotherapy.
@nl
type
label
Posttreatment TNM staging is a ...... chemotherapy and radiotherapy.
@en
Posttreatment TNM staging is a ...... chemotherapy and radiotherapy.
@nl
prefLabel
Posttreatment TNM staging is a ...... chemotherapy and radiotherapy.
@en
Posttreatment TNM staging is a ...... chemotherapy and radiotherapy.
@nl
P2093
P1476
Posttreatment TNM staging is a ...... chemotherapy and radiotherapy.
@en
P2093
Alexander K P Chan
Alfred Wong
Daryl Jenken
Donald Buie
Douglas Johnson
John Heine
P304
P356
10.1016/J.IJROBP.2004.06.206
P407
P577
2005-03-01T00:00:00Z